TuisRO • SWX
add
Roche Holding AG
Vorige sluiting
CHFÂ 286,80
Dagwisseling
CHFÂ 285,60 - CHFÂ 288,60
Jaarwisseling
CHFÂ 244,00 - CHFÂ 333,60
Markkapitalisasie
250,77Â mjd CHF
Gemiddelde volume
31,26Â k
P/V-verhouding
27,77
Dividend-opbrengs
3,38%
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CHF) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 15,82Â mjd | 6,08% |
Bedryfskoste | 7,30Â mjd | -0,75% |
Netto inkomste | 1,01Â mjd | -53,70% |
Netto winsgrens | 6,38 | -56,36% |
Wins per aandeel | — | — |
EBITDA | 5,19Â mjd | 19,26% |
Effektiewe belastingkoers | 30,25% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CHF) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 17,33Â mjd | 64,90% |
Totale bates | 101,80Â mjd | 12,53% |
Totale aanspreeklikheid | 65,64Â mjd | 14,75% |
Totale ekwiteit | 36,16 mjd | — |
Uitstaande aandele | 795,40 m | — |
Prys om te bespreek | 7,18 | — |
Opbrengs op bates | 10,77% | — |
Opbrengs op kapitaal | 15,11% | — |
Kontantvloei
Netto kontantverandering
(CHF) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,01Â mjd | -53,70% |
Kontant van bedrywe | 6,09Â mjd | 48,59% |
Kontant van beleggings | -4,26Â mjd | 16,07% |
Kontant van finansiering | -685,00Â m | -133,79% |
Netto kontantverandering | 1,08Â mjd | 29,89% |
Beskikbare kontantvloei | 2,19Â mjd | 18,88% |
Meer oor
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
Gestig
01 Okt. 1896
Hoofkwartier
Webwerf
Werknemers
103Â 249